SARS-CoV-2-IN-59
Product Specifications
UNSPSC Description
SARS-CoV-2-IN-59 (compound E07), an imidazoline derivative, is a non-peptide small molecule inhibitor of SARS-CoV-2 that targets the main protease (Mpro) of the coronavirus. SARS-CoV-2-IN-59 has a strong interaction with residues on Mpro (Met 165, Gln 166, Met 165, His 41, Gln 189)[1].
Target Antigen
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-in-59.html
Solubility
10 mM in DMSO
Smiles
N#CC1=CC=C(C2=NCCN2)C=C1
Molecular Weight
171.20
References & Citations
[1]Azimi S, et al. Green and rapid and instrumental one-pot method for the synthesis of imidazolines having potential anti-SARS-CoV-2 main protease activity. Sustain Chem Pharm. 2023 Sep;34:101136.. .
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-W348072/SARS-CoV-2-IN-59-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-W348072/
Clinical Information
No Development Reported
CAS Number
850786-33-3
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![1H-Pyrrolo[2,3-b]pyridine-3-sulfonic acid (4-fluoro-phenyl) -amide](https://cdn.genprice.uk/genprice/genprice4.png)
